Recent News

Pursuing a Path of Regulatory Rigor: Taking Medtech, Regenerative Medicine to the Next Level

Friday, August 16

The medical device industry is facing a generational change in the regulation and validation of its products. Today, more than ever, physicians, patients, and payers are demanding solid evidence that the devices they prescribe, use, and pay for performs to the highest standards and is backed by significant clinical data. In many cases, these standards are being driven by hospital value analysis committees, who increasingly act as gatekeepers for their institutions.

Read More

Research: COPD Trial at Christiana Care

Thursday, July 11

Christiana Care Health System is participating in national research that may provide a non-invasive alternative to a ventilator for patients with severe chronic obstructive pulmonary disease (COPD).

Read More

ALung Announces the Achievement of a Key Milestone in the U.S. Based VENT-AVOID Trial and Continued Progress Towards Completion of the Trial

Thursday, July 11

PITTSBURGH--(BUSINESS WIRE)--ALung Technologies, Inc., the leading provider of low-flow extracorporeal carbon dioxide removal (ECCO2R) technologies for treating patients with acute respiratory failure, announced today the achievement of a major milestone with the enrollment of the 50th patient in its U.S. based VENT-AVOID clinical trial.

Read More

ALung Announces that the Independent Data and Safety Monitoring Board (DSMB) Recommends Continuation of VENT-AVOID Trial

Tuesday, July 02

PITTSBURGH--(BUSINESS WIRE)--ALung Technologies, Inc., the leading provider of low-flow extracorporeal carbon dioxide removal (ECCO2R) technologies for treating patients with acute respiratory failure, announced today the achievement of a major milestone in its U.S. based VENT-AVOID clinical trial and reports continued progress in its clinical trial programs.

Read More

Edge Case Research Secures $7M Towards Improving the Safety and Reliability of Autonomous Vehicles

Wednesday, June 12

Pittsburgh, PA – Edge Case Research (Edge Case), founded by the recognized world leaders in autonomous system safety and autonomous vehicle safety, announced it secured $7 million in investment funding. The investment will expand the development of Hologram, an intelligent safety assessment platform for autonomous vehicle software that operates at the speed of modern machine learning development.

Read More

Exagen and the Lupus Foundation of America Partner on New Initiative to Reduce the Time to an Accurate Lupus Diagnosis

Tuesday, May 07

SAN DIEGO, CA AND WASHINGTON, DC, FEBRUARY 26, 2019 (GLOBE NEWSWIRE) ‐‐ Exagen, a life science company serving the rheumatology specialty, and the Lupus Foundation of America, the national force devoted to solving the mystery of lupus, announced a new initiative to educate those at risk for lupus about the disease and its symptoms in an effort to reduce the time it can take for an accurate lupus diagnosis.

Read More